High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer
Urologic Oncology: Seminars and Original Investigations Apr 05, 2018
Li Q, et al. - The function of NORAD in bladder cancer (BC) was determined. They also verified if NORAD could be used as a biomarker to determine the preoperative presence of progression and lymph node metastasis. It is the first study investigating NORAD and its implications in BC. For the overall survival of patients with transitional BC, high NORAD expression could serve as an independent prognostic factor.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries